Azatadin: Perbedaan antara revisi
Tampilan
Konten dihapus Konten ditambahkan
←Membuat halaman berisi '{{Drugbox | verifiedrevid = 477164914 | IUPAC_name = 11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5''H''-benzo[5,6]cyclohepta[1,2-''b'']pyridine | image = Azatadine.svg <!--Clinical data--> | tradename = Optimine | Drugs.com = {{drugs.com|CONS|azatadine}} | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = B | legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> | legal_UK = <!-- GSL / P / POM / CD --> | legal_US = <!--Identifiers--> | IUPHAR_liga...' Tag: kemungkinan perlu dirapikan Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
Baris 1: | Baris 1: | ||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = 477164914 |
| verifiedrevid = 477164914 |
||
| IUPAC_name = 11-(1- |
| IUPAC_name = 11-(1-Metilpiperidin-4-ilidena)-6,11-dihidro-5''H''-benzo[5,6]siklohepta[1,2-''b'']piridina |
||
| image = Azatadine.svg |
| image = Azatadine.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
Baris 39: | Baris 39: | ||
}} |
}} |
||
''' |
'''Azatadin''' adalah obat [[antihistamin]] dan [[antikolinergik]] generasi pertama yang disintesis pada tahun 1963 oleh Schering-Plough, bekas perusahaan farmasi Amerika Serikat.<ref>{{cite journal | vauthors = Katelaris C | title = Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis | journal = Asian Pacific Journal of Allergy and Immunology | volume = 8 | issue = 2 | pages = 103–7 | date = December 1990 | pmid = 1982614 }}</ref><ref>{{cite journal | vauthors = Small P, Barrett D, Biskin N | title = Effects of azatadine, terfenadine, and astemizole on allergen-induced nasal provocation | journal = Annals of Allergy | volume = 64 | issue = 2 Pt 1 | pages = 129–31 | date = February 1990 | pmid = 1968324 }}</ref> |
||
Obat ini dipatenkan pada tahun 1967.<ref>{{cite patent | title = Azatadine | inventor = Villani FJ, Caldwell W | country = US | number = 3326924 | gdate = 1967 }}</ref> Obat ini telah digantikan oleh [[loratadin]] dan [[desloratadin]].<ref>{{cite book | vauthors = Horak F | chapter = Antialergic and Vasoactive Drugs for Allergic Rhinitis. Chapter 4 | title = Allergy Frontiers:Therapy and Prevention. | volume = 5 | veditors = Pawankar R, Holgate ST, Rosenwasser LJ | publisher = Springer Science & Business Media | date = 2010 | isbn = 9784431993629 }}</ref>{{rp|53}} dan persetujuan pemasarannya telah banyak ditarik.<ref>{{cite web | work = Drugs.com | url = https://www.drugs.com/mtm/azatadine.html | title = Azatadine }}</ref><ref>{{cite web | work = Federal Register 70 FR 10651 | date = 2005 | url = https://www.federalregister.gov/articles/2005/03/04/05-4158/hospira-inc-et-al-withdrawal-of-approval-of-76-new-drug-applications-and-60-abbreviated-new-drug | author = Food and Drug Administration | title = Docket No.2005N-0058: Hospira, Inc. et al.; Withdrawal of Approval of 76 New Drug Applications and 60 Abbreviated New Drug Applications }} </ref><ref>{{cite web | work = Federal Register 72 FR 8184 | date = 2007 | url = http://www.gpo.gov/fdsys/pkg/FR-2007-02-23/html/E7-3043.htm | author = Food and Drug Administration | title = Docket No. 2004P-0262: Withdrawal of Approval of 128 Suitability Petitions }}</ref><ref>{{cite web | work = Department of Economic and Social Affairs of the United Nations Secretariat | url = https://www.un.org/esa/coordination/CL12.pdf | title = Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments Twelfth Issue: Pharmaceuticals | publisher = United Nations | location = New York | date = 2005 }}</ref>{{rp|290}}<ref>{{cite web | work = FDA | url = https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ucm283497.htm | title = OGD Suitability Tracking Report (Sorted by Drug Name) }}</ref> |
|||
Obat ini dipatenkan pada tahun 1967.[3] Obat ini telah digantikan oleh loratadine dan desloratadine.[4]: 53 dan persetujuan pemasarannya telah banyak ditarik.[5][6][7][8]: 290 [9] |
|||
== Referensi == |
== Referensi == |
||
{{Reflist}} |
{{Reflist}} |
Revisi per 15 Oktober 2024 15.35
Nama sistematis (IUPAC) | |
---|---|
11-(1-Metilpiperidin-4-ilidena)-6,11-dihidro-5H-benzo[5,6]siklohepta[1,2-b]piridina | |
Data klinis | |
Nama dagang | Optimine |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Kat. kehamilan | B(US) |
Status hukum | ? |
Pengenal | |
Nomor CAS | 3964-81-6 |
Kode ATC | R06AX09 |
PubChem | CID 19861 |
Ligan IUPHAR | 7119 |
DrugBank | DB00719 |
ChemSpider | 18709 |
UNII | 94Z39NID6C |
KEGG | D07482 |
ChEBI | CHEBI:2946 |
ChEMBL | CHEMBL946 |
Data kimia | |
Rumus | C20H22N2 |
SMILES | eMolecules & PubChem |
|
Azatadin adalah obat antihistamin dan antikolinergik generasi pertama yang disintesis pada tahun 1963 oleh Schering-Plough, bekas perusahaan farmasi Amerika Serikat.[1][2]
Obat ini dipatenkan pada tahun 1967.[3] Obat ini telah digantikan oleh loratadin dan desloratadin.[4] dan persetujuan pemasarannya telah banyak ditarik.[5][6][7][8][9]
Referensi
- ^ Katelaris C (December 1990). "Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis". Asian Pacific Journal of Allergy and Immunology. 8 (2): 103–7. PMID 1982614.
- ^ Small P, Barrett D, Biskin N (February 1990). "Effects of azatadine, terfenadine, and astemizole on allergen-induced nasal provocation". Annals of Allergy. 64 (2 Pt 1): 129–31. PMID 1968324.
- ^ US 3326924, Villani FJ, Caldwell W, "Azatadine", dikeluarkan tanggal 1967
- ^ Horak F (2010). "Antialergic and Vasoactive Drugs for Allergic Rhinitis. Chapter 4". Dalam Pawankar R, Holgate ST, Rosenwasser LJ. Allergy Frontiers:Therapy and Prevention. 5. Springer Science & Business Media. ISBN 9784431993629.
- ^ "Azatadine". Drugs.com.
- ^ Food and Drug Administration (2005). "Docket No.2005N-0058: Hospira, Inc. et al.; Withdrawal of Approval of 76 New Drug Applications and 60 Abbreviated New Drug Applications". Federal Register 70 FR 10651.
- ^ Food and Drug Administration (2007). "Docket No. 2004P-0262: Withdrawal of Approval of 128 Suitability Petitions". Federal Register 72 FR 8184.
- ^ "Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments Twelfth Issue: Pharmaceuticals" (PDF). Department of Economic and Social Affairs of the United Nations Secretariat. New York: United Nations. 2005.
- ^ "OGD Suitability Tracking Report (Sorted by Drug Name)". FDA.